Detalhe da pesquisa
1.
Adjuvant nivolumab versus placebo following radical surgery for high-risk muscle-invasive urothelial carcinoma: a subgroup analysis of Japanese patients enrolled in the phase 3 CheckMate 274 trial.
Jpn J Clin Oncol
; 53(1): 16-25, 2023 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36300304
2.
PKC phosphorylates MARCKS Ser159 not only directly but also through RhoA/ROCK.
Biochem Biophys Res Commun
; 345(1): 156-61, 2006 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-16677610